3 days ago
FDMT
AnalystsTazeen AhmadTazeen Ahmad's Stock Forecasts
AnalystsTazeen Ahmad
Analyst Ranking
Top 16%
#648 out of 4241 analysts
Average Return
+5.35%
Win Rate
53%39 out of 73
Risk vs Reward
Poor
Good
Tazeen Ahmad's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunomedics IncIMMU | +339.08% | $20.01 | $87.86 | 2019-12-19 - 2020-10-22 | Strong Buy |
Argenx SeARGX | +133.81% | $157.46 | $368.16 | 2020-02-09 - 2021-02-10 | Strong Buy |
Avexis IncAVXS | +127.40% | $95.79 | $217.83 | 2017-11-09 - 2018-05-15 | Strong Buy |
Galera Therapeutics IncGRTX | +103.14% | $1.59 | $3.23 | 2023-02-15 - 2023-06-09 | Strong Buy |
Acadia Pharmaceuticals IncACAD | +100.00% | $20.24 | $40.48 | 2018-10-09 - 2019-10-10 | Strong Buy |
Tazeen Ahmad Analyst Color
Get additional color on Tazeen Ahmad's coverage of popular stocks
a month ago
SRPT
4 months ago
GRTX
8 months ago
PRTA
a year ago
ASND
Tazeen Ahmad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
4d Molecular Therapeutics IncFDMT | 2 | Strong Buy | $33.00 | +50.20% | Maintains | 3 days ago |
Annexon IncANNX | 2 | Hold | $3.00 | +6.76% | Downgrades | 16 days ago |
Ptc Therapeutics IncPTCT | 8 | Sell | $42.00 | -2.33% | Maintains | 17 days ago |
Sage Therapeutics IncSAGE | 10 | Strong Buy | $61.00 | +2.45% | Maintains | 19 days ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $26.00 | +5.18% | Maintains | 20 days ago |
Sarepta Therapeutics IncSRPT | 1 | Strong Buy | $176.00 | +37.86% | Maintains | a month ago |
Incyte CorpINCY | 1 | Hold | $84.00 | +37.61% | Downgrades | a month ago |
Adc Therapeutics SaADCT | 2 | Sell | $2.00 | -20.63% | Downgrades | 2 months ago |
Ascendis Pharma AASND | 5 | Strong Buy | $92.00 | -0.71% | Maintains | 2 months ago |
Biontech SeBNTX | 5 | Strong Buy | $194.00 | +77.57% | Maintains | 2 months ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $17.00 | +32.71% | Maintains | 2 months ago |
Galera Therapeutics IncGRTX | 2 | Strong Buy | $7.00 | +116.72% | Upgrades | 4 months ago |
Cyteir Therapeutics IncCYT | 1 | Hold | $2.00 | -5.66% | Downgrades | 4 months ago |
Fate Therapeutics IncFATE | 1 | Sell | $4.00 | -17.86% | Downgrades | 5 months ago |
Sqz Biotechnologies CoSQZ | 2 | Sell | $2.00 | +270.37% | Downgrades | 6 months ago |
Prelude Therapeutics IncPRLD | 4 | Sell | $6.00 | +10.70% | Downgrades | 7 months ago |
Surrozen IncSRZN | 3 | Sell | $1.00 | +66.11% | Downgrades | 7 months ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $39.00 | +18.79% | Initiates Coverage On | 8 months ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Buy | N/A | N/A | Upgrades | 8 months ago |
Pharvaris NvPHVS | 2 | Sell | $13.00 | +14.74% | Downgrades | 10 months ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Hold | $20.00 | +14.74% | Upgrades | 10 months ago |
Praxis Precision Medicines IncPRAX | 1 | Hold | $4.00 | N/A | Downgrades | a year ago |
Pepgen IncPEPG | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Molecular Templates IncMTEM | 1 | Sell | $1.50 | N/A | Downgrades | a year ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Hold | $14.00 | N/A | Downgrades | a year ago |
Pyxis Oncology IncPYXS | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Quince Therapeutics IncQNCX | 1 | Sell | N/A | N/A | Downgrades | 2 years ago |
Arvinas IncARVN | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $162.00 | N/A | Upgrades | 2 years ago |
Akouos IncAKUS | 2 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Orphazyme AORPHY | 1 | Sell | $5.00 | N/A | Downgrades | 2 years ago |
Argenx SeARGX | 2 | Strong Buy | $298.00 | N/A | Maintains | 3 years ago |
89bio IncETNB | 1 | Strong Buy | $43.00 | N/A | Upgrades | 3 years ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 3 years ago |
Fulcrum Therapeutics IncFULC | 2 | Sell | $11.00 | N/A | Downgrades | 3 years ago |
Clovis Oncology IncCLVSQ | 1 | Sell | $6.00 | N/A | Downgrades | 3 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 3 years ago |
Dbv Technologies SaDBVT | 1 | Strong Buy | $30.00 | N/A | Maintains | 5 years ago |
Tesaro IncTSRO | 4 | Hold | $39.00 | N/A | Maintains | 5 years ago |
Spero Therapeutics IncSPRO | 2 | Sell | $9.00 | N/A | Downgrades | 5 years ago |
Pacira Biosciences IncPCRX | 3 | Hold | $48.00 | N/A | Maintains | 5 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | $25.00 | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 3 | Strong Buy | $200.00 | N/A | Maintains | 5 years ago |
Ptc IncPTC | 3 | Hold | $102.00 | N/A | Maintains | 5 years ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $102.00 | N/A | Maintains | 5 years ago |
Seagen IncSGEN | 1 | Hold | $68.00 | N/A | Maintains | 5 years ago |
Avexis IncAVXS | 1 | Strong Buy | $112.00 | N/A | Maintains | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.